| 1 |
29246296 | Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes. | 2017 Dec 15 |
1 |
| 2 |
26718027 | Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines. | 2016 Feb |
1 |
| 3 |
27579319 | Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells. | 2016 |
1 |
| 4 |
24637737 | Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides. | 2014 |
1 |
| 5 |
23353574 | Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines. | 2013 Feb |
1 |
| 6 |
23480956 | A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery. | 2013 May |
1 |
| 7 |
17224645 | Bcl2/bcl-xL inhibitor engenders apoptosis and increases chemosensitivity in mesothelioma. | 2007 Feb |
2 |
| 8 |
17697540 | [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549]. | 2007 Aug |
1 |
| 9 |
18029612 | Inhibition of bcl-xL expression by antisense oligonucleotides containing various bridged nucleic acids (BNAs). | 2007 |
1 |
| 10 |
16374552 | Cyclin D1 overexpression induces epidermal growth factor-independent resistance to apoptosis linked to BCL-2 in human A431 carcinoma. | 2006 Jan |
1 |
| 11 |
16412215 | Modulation of 5' splice site selection using tailed oligonucleotides carrying splicing signals. | 2006 Jan 13 |
1 |
| 12 |
16686729 | Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes. | 2006 Jun |
2 |
| 13 |
17150931 | Antisense activity of 2',4'-BNA targeted to bcl-xL gene in HepG2 cell. | 2006 |
2 |
| 14 |
17172421 | Chemosensitization of carcinoma cells using epithelial cell adhesion molecule-targeted liposomal antisense against bcl-2/bcl-xL. | 2006 Dec |
1 |
| 15 |
15820062 | [Regulatory effect of STAT5 decoy oligonucleotides on trans-activation of bcl-x gene promoter in K562 cells]. | 2005 Apr |
2 |
| 16 |
15917659 | Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. | 2005 Jul |
1 |
| 17 |
16085054 | Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. | 2005 Aug 15 |
1 |
| 18 |
16275990 | A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells. | 2005 Nov |
8 |
| 19 |
16299354 | Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo. | 2005 |
1 |
| 20 |
14676192 | Hypoxia selection of death-resistant cells. A role for Bcl-X(L). | 2004 Mar 5 |
1 |
| 21 |
14960579 | Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. | 2004 May 7 |
1 |
| 22 |
14985457 | Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect. | 2004 Feb |
2 |
| 23 |
15141012 | Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma. | 2004 May |
4 |
| 24 |
15159020 | Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel. | 2004 Jun 25 |
1 |
| 25 |
15332326 | BCNU down-regulates anti-apoptotic proteins bcl-xL and Bcl-2 in association with cell death in oligodendroglioma-derived cells. | 2004 Jul |
1 |
| 26 |
15375570 | Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation. | 2004 Oct |
1 |
| 27 |
15379893 | P2Y receptors activate neuroprotective mechanisms in astrocytic cells. | 2004 Oct |
1 |
| 28 |
15505422 | Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma. | 2004 Nov |
1 |
| 29 |
15570009 | Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells. | 2004 Nov 15 |
1 |
| 30 |
15625915 | A functionally improved locked nucleic acid antisense oligonucleotide inhibits Bcl-2 and Bcl-xL expression and facilitates tumor cell apoptosis. | 2004 |
3 |
| 31 |
12543166 | Sensitization of head and neck squamous cell carcinoma cells to Fas-mediated apoptosis by the inhibition of Bcl-X(L) expression. | 2003 Feb |
1 |
| 32 |
12558990 | Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death. | 2003 Jan |
2 |
| 33 |
12800189 | Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment. | 2003 Aug 20 |
2 |
| 34 |
12855666 | Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. | 2003 Jul |
1 |
| 35 |
14520471 | Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells. | 2003 Oct 6 |
5 |
| 36 |
14522969 | Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides. | 2003 Dec 12 |
1 |
| 37 |
14627985 | Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity. | 2003 Nov 20 |
2 |
| 38 |
11792421 | Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. | 2002 Mar |
1 |
| 39 |
11874491 | Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages. | 2002 Mar |
4 |
| 40 |
11948488 | Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy. | 2002 May 1 |
3 |
| 41 |
11986224 | Constitutive nuclear factor-kappaB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins. | 2002 May 15 |
3 |
| 42 |
12031489 | Analysis of ribosyl-modified, mixed backbone analogs of a bcl-2/bcl-xL antisense oligonucleotide. | 2002 Jun 7 |
5 |
| 43 |
12063468 | Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product. | 2002 Jun |
5 |
| 44 |
12070027 | Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. | 2002 Jul 1 |
1 |
| 45 |
12218266 | Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells. | 2002 Sep |
5 |
| 46 |
12381725 | Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. | 2002 Dec 20 |
1 |
| 47 |
12393593 | Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistance. | 2002 Nov 15 |
1 |
| 48 |
12452453 | Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide. | 2002 Nov |
1 |
| 49 |
12570053 | BcI-xL antisense treatment sensitizes Bcl-xL-overexpressing squamous cell carcinoma cells to carboplatin. | 2002 Dec |
4 |
| 50 |
11259472 | Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. | 2001 Mar 21 |
7 |